[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BioCentury Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::227778014.png) @BioCentury BioCentury

BioCentury posts on X about jacob, finance, kong, hong kong the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::227778014/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::227778014/c:line/m:interactions.svg)

- X Week XXXXXX +2,560%
- X Month XXXXXXX +736%
- X Months XXXXXXX +63%
- X Year XXXXXXX +5.50%

### Mentions: X [#](/creator/twitter::227778014/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::227778014/c:line/m:posts_active.svg)


### Followers: XXXXXX [#](/creator/twitter::227778014/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::227778014/c:line/m:followers.svg)

- X Week XXXXXX +0.48%
- X Month XXXXXX +0.81%
- X Months XXXXXX +1.40%
- X Year XXXXXX +2.60%

### CreatorRank: XXXXXXX [#](/creator/twitter::227778014/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::227778014/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::227778014/influence)
---

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [travel destinations](/list/travel-destinations)  [technology brands](/list/technology-brands) 

**Social topic influence**
[jacob](/topic/jacob), [finance](/topic/finance), [kong](/topic/kong), [hong kong](/topic/hong-kong), [$192m](/topic/$192m), [novartis](/topic/novartis), [$700m](/topic/$700m), [$abbv](/topic/$abbv), [money](/topic/money), [vista](/topic/vista)

**Top assets mentioned**
[Novartis AG (NVS)](/topic/novartis) [AbbVie Inc (ABBV)](/topic/$abbv) [Alphabet Inc Class A (GOOGL)](/topic/$googl)
### Top Social Posts [#](/creator/twitter::227778014/posts)
---
Top posts by engagements in the last XX hours

"Biotech venture financing fell in 1H25 both in dollars raised and number of rounds: a BioCentury Data Byte"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945627055279800750) 2025-07-16 23:30:12 UTC 16.2K followers, 1344 engagements


"Rare disease setbacks for Ultragenyx mid-stage win for Rhythm. Plus: Astrazeneca and Takeda preparing submissions after Phase III readouts in this weeks Clinical Report"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945249566049095747) 2025-07-15 22:30:12 UTC 16.2K followers, XXX engagements


"Third patient dies from acute liver failure caused by a Sarepta gene therapy"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945996977247793589) 2025-07-18 00:00:08 UTC 16.2K followers, 90.7K engagements


"Lundbeckfondens Jacob Falck Hansen becomes CEO of portfolio company Vesper Bio. Also in BioCentury's Management Moves Column:Oncolytics reunitesAromando with new CEO Kelly and updates fromGalderma JadeOutlookAvacta andZura"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1940221418089623563) 2025-07-02 01:30:08 UTC 16.2K followers, XXX engagements


"Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946321633376944468) 2025-07-18 21:30:12 UTC 16.2K followers, XXX engagements


"Novartis names Mehta new CFO. Plus: Biontechs chief strategy officer steps down and updates from Vor Vivid Dx in BioCentury's Management Tracks"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946012088293371953) 2025-07-18 01:00:11 UTC 16.2K followers, XXX engagements


"Sino Biopharma acquires Lanova in rare China-China takeout. Plus AbbVie pays $700M up front for trispecific mAb in development formultiple myeloma in BioCentury's latest deals report"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945279766296215732) 2025-07-16 00:30:12 UTC 16.2K followers, XXX engagements


"Seed/Series A money up in 1H25 but mostly a few companies raising monster rounds: a BioCentury Data Byte"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946291423717863789) 2025-07-18 19:30:10 UTC 16.2K followers, XXX engagements


"Science Spotlight:Targeting VISTA to improve radiotherapy. BioCenturys translational roundup also includes a new glycosylation enzyme a multi-modal vaccine strategy and nine papers with links to neurology companies"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945634612102779222) 2025-07-17 00:00:14 UTC 16.2K followers, XXX engagements


"BioCentury's latest management tracks: Stumpe an alum of Tempus and Google named chief tech officer at Danaher. Plus: Updates from Cardiff Regenics X-chem"  
![@BioCentury Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::227778014.png) [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1938756773403296004) 2025-06-28 00:30:09 UTC 16.2K followers, XXX engagements